The level of MDA in BALF might reflect oxidative tissue damage in patients with mild MAC pulmonary disease.

S. Oh-Ishi (Naka-gun, Japan), K. Nemoto (Naka-gun, Japan), H. Oshima (Naka-gun, Japan), K. Kawashima (Naka-gun, Japan), Y. Yabuuchi (Naka-gun, Japan), T. Shimada (Naka-gun, Japan), Y. Kitaoka (Naka-gun, Japan), H. Hirano (Naka-gun, Japan), N. Arai (Naka-gun, Japan), K. Hyodo (Naka-gun, Japan), A. Nakazawa (Naka-gun, Japan), J. Kanazawa (Naka-gun, Japan), Y. Miura (Naka-gun, Japan), S. Usui (Naka-gun, Japan), K. Hayashihara (Naka-gun, Japan), S. Fukai (Naka-gun, Japan), T. Saito (Naka-gun, Japan)

Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Session: New investigations of bronchiectasis and non-tuberculous mycobacteria
Session type: E-poster session
Number: 3340
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Oh-Ishi (Naka-gun, Japan), K. Nemoto (Naka-gun, Japan), H. Oshima (Naka-gun, Japan), K. Kawashima (Naka-gun, Japan), Y. Yabuuchi (Naka-gun, Japan), T. Shimada (Naka-gun, Japan), Y. Kitaoka (Naka-gun, Japan), H. Hirano (Naka-gun, Japan), N. Arai (Naka-gun, Japan), K. Hyodo (Naka-gun, Japan), A. Nakazawa (Naka-gun, Japan), J. Kanazawa (Naka-gun, Japan), Y. Miura (Naka-gun, Japan), S. Usui (Naka-gun, Japan), K. Hayashihara (Naka-gun, Japan), S. Fukai (Naka-gun, Japan), T. Saito (Naka-gun, Japan). The level of MDA in BALF might reflect oxidative tissue damage in patients with mild MAC pulmonary disease.. 3340

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005

The nature of inflammation and tissue damage in COPD
Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Year: 2004

Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012


Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Alveolar antioxidant status in patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 24: 994-999
Year: 2004



The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002

Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairment
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 119s
Year: 2003

Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Extracorporal photosensitation in bleomycin-induced lung injury decreases IL-10 protein levels in BAL but not the level of inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005

Comparison of oxidative stress markers in 3 matrices (EBC, blood and urine) in patients with occupational lung fibrosis and control subjects
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010

Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016


High CAT score predicts lung parenchymal damage in COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD)
Source: Eur Respir J 2007; 30: Suppl. 51, 110s
Year: 2007

Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019